跳至主要内容
临床试验/NL-OMON50968
NL-OMON50968尚未招募不适用

Effectiveness of methylphenidate in adults with phenylketonuria and attention-deficit/hyperactivity disorder: An N-of-1 series - MPH4PK

Academisch Medisch Centrum0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Minimum age of 18 years.
  • - A definite diagnosis of classical PKU according to well-established
  • guidelines.
  • - Meet DSM-5 criteria for ADHD and diagnosed with ADHD by an expert
  • multidisciplinary team consisting of an ID physician, a psychologist, and a
  • psychiatrist.
  • - Presence of a patient*s caregiver for proxy-reports.

排除标准

  • - Unable to take and/or send in dried blood spots.
  • - Presence of ADHD in first- and second-degree relatives.
  • - Presence of a contra-indication for treatment with methylphenidate (e.g.
  • cardiovascular disease).
  • - Planned surgery and/or general anaesthesia during the trial.
  • - Pregnancy.
  • - Breastfeeding (females).
  • - During treatment with non-selective, irreversible monoamine oxidase (MAO)
  • inhibitors, or within a minimum of one month of discontinuing those drugs.
  • - Current substance or alcohol abuse.
  • - Unable to swallow tablets / capsules.

研究者

相似试验